The expression and prognostic role of cyclin D1, cyclin E, and p21 (WAF1/CIP1) were immunohistochemically investivated in 413 curatively resected gastric carcinomas. p21 was expressed in 65β’4 per cent (n=270), cyclin D1 in 23β’7 per cent (n=98), and cyclin E in 13β’6 per cent (n=56) of the tumours. Th
Evaluation of p21 WAF1/CIP1 and cyclin D 1 expression in the progression of superficial bladder cancer
β Scribed by Liukkonen, T. ;Lipponen, P. ;Raitanen, M. ;Kaasinen, E. ;Ala-Opas, M. ;Rajala, P. ;Kosma, V.-M.
- Book ID
- 105934303
- Publisher
- Springer
- Year
- 2000
- Tongue
- English
- Weight
- 161 KB
- Volume
- 28
- Category
- Article
- ISSN
- 0300-5623
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
BACKGROUND. p21(waf1/cip1) protein is a cyclin-dependent kinase inhibitor able to arrest the cell cycle at the G1 phase by inhibiting DNA replication. The expression of p21(waf1/cip1) and its prognostic value in prostate cancer are largely unexplored. METHODS. We used immunohistochemistry to analyze
WAF1/Cip1/Sdi1 (p21) is the prototype of a family of proteins that inhibit cyclin-dependent kinases and regulate cell cycle progression in eukaryotic cells. In addition to normal cell cycle progression, p21 is involved in growth suppression mediated by p53 and transforming growth factor beta (TGFbet
BACKGROUND. Barrett esophagus predisposes individuals to esophageal carcinoma, which develops from intermediate stages of tissue dysplasia primarily in the vicinity of the gastroesophageal junction. Understanding the cellular and molecular events in the progression of Barrett esophagus to adenocarci